Adc Therapeutics Sa (ADCT)

EBITDA Growth

-11.50%

Quarterly · Period ending:

ADCT logo

ADCT EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-11.50%
ADCT Quarterly EBITDA YoY % (20.62% → -11.50%)
High-resolution chart · PNG

ADCT ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Adc Therapeutics Sa EBITDA Growth — Quarterly
Period endingEBITDA Growth
-11.4988%
20.1736%
133.528%
7.569%
-85.6776%
20.7607%
43.2327%
9.7292%
46.5569%
30.2545%
-180.2331%
16.4758%
25.7482%
-479.5387%
74.306%
38.7111%
19.0992%
83.5797%
12.9664%
-259.0158%
44.7414%
-13.8747%
-52.8999%
41.6626%
-448.2746%
-71.4646%
-12.2342%
1.328%
27.5839%
20.6216%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.